Viewing Study NCT00003369


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-01-25 @ 4:33 AM
Study NCT ID: NCT00003369
Status: COMPLETED
Last Update Posted: 2012-06-14
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
Sponsor: SWOG Cancer Research Network
Organization:

Organization Data

Organization:
Class: NETWORK
Study ID: CDR0000066358
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View